| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |